Received date: 2018-07-10
Revised date: 2018-09-13
Online published: 2018-10-26
Supported by
the National Natural Science Foundation of China(31430002);the National Natural Science Foundation of China(31320103911);the National Natural Science Foundation of China(31500690);the National Natural Science Foundation of China(31670052);the National Natural Science Foundation of China(31600017);the National Key Research And Development Program of China(2017YFD0201207);the Fundamental Research Funds for the Central Universities(22221818014);the Major Basic Program of the Natural science Foundation of Shandong Province(ZR2017ZB0206);the Shandong Taishan Scholar Program of China for L.Z.
Avermectins, are pesticides of fermentation products with high efficacy and low toxicity and play important roles in food and agricultural product safety, animal and human health. Ivermectins, the derivatives of avermectins, are used to treat Onchocerciasis, also known as River Blindness. Thanks to these discoveries, more than 200 million Africans are lucky to be exempted from blindness. Great efforts have been made on better understanding of the microbial production system of avermectins through genetic engineering in China. Starting from scratch, Chinese avermectin industry has experienced a comprehensive technological innovation with significantly improved yield, titer and productivity of avermectins, and became the exclusive supplier for the global market. The success of avermectin industry innovation in China not only shed lights on the intelligent yield improvement of other microbial natural product drugs, but also gained wide international recognition. We provide here an overview of the discovery and development of basic and applied research of avermectins, especially historical evolution of avermectins made in China, which will benefit industrial development of microbial drugs in China.
Key words: avermectins; ivermectins; genetic engineering; yield improvement
Ying Wen, Lixin Zhang . Avermectins, intelligently made in China[J]. Hereditas(Beijing), 2018 , 40(10) : 888 -899 . DOI: 10.16288/j.yczz. 18-194
| [1] | Chen JS, Liu M, Zhang LX . Avermectin, from winning the Nobel Prize to "innovation in China". Acta microbiol Sin, 2016,56(3):543-558. | |||
| [1] | 陈金松, 刘梅, 张立新 . 从阿维菌素获得诺贝尔奖到中国创造. 微生物学报, 2016,56(3):543-558. | |||
| [2] | Burg RW, Miller BM, Baker EE, Birnbaum J, Currie SA, Hartman R, Kong YL, Monaghan RL, Olson G, Putter I, Tunac JB, Wallick H, Stapley EO, Oiwa R, Omura S . Avermectins, new family of potent anthelmintic agents: producing organism and fermentation. Antimicrob Agents Chemoth, 1979,15(3):361-367. | |||
| [3] | Miller TW, Chaiet L, Cole DJ, Cole LJ, Flor JE, Goegelman RT, Gullo VP, Joshua H, Kempf AJ, Krellwitz WR, Monaghan RL, Ormond RE, Wilson KE, Albers- Sch?nberg G, Putter I . Avermectins, new family of potent anthelmintic agents: isolation and chromatographic properties. Antimicrob Agents Chemoth, 1979,15(3):368-371. | |||
| [4] | Egerton JR, Ostlind DA, Blair LS, Eary CH, Suhayda D, Cifelli S, Riek RF, Campbell WC . Avermectins, new family of potent anthelmintic agents: efficacy of the B1a component. Antimicrob Agents Chemoth, 1979,15(3):372-378. | |||
| [5] | Chabala JC, Mrozik H, Tolman RL, Eskola P, Lusi A, Peterson LH, Woods MF, Fisher MH, Campbell WC, Egerton JR, Ostlind DA . Ivermectin, a new broad-spectrum antiparasitic agent. J Med Chem, 1980,23(10):1134-1136. | |||
| [6] | Campbell WC, Fisher MH, Stapley EO, Albers-Sch?nberg G, Jacob TA . Ivermectin: A potent new antiparasitic agent. Science, 1983,221(4613):823-828. | |||
| [7] | Kass IS, Wang CC, Walrond JP, Stretton AO . Avermectin B1a, a paralysing anthelmintic that affects interneurons and inhibiting motoneurons in Ascaris. Proc Natl Acad Sci USA, 1980,77(10):6211-6215. | |||
| [8] | McKellar QA, Benchaoui HA . Avermectins and milbemycins. J Vet Pharmacol Ther, 1996,19(5):331-351. | |||
| [9] | Wolstenholme AJ, Rogers AT . Glutamate-gated chloride channels and the mode of action of the avermectin/ milbemycin anthelmintics. Parasitology, 2005,131(Supp1.):S85-S95. | |||
| [10] | Lim LE, Vilcheze C, Ng C, Jacobs WR Jr, Ramon-Garcia S, Thompson CJ . Anthelmintic avermectins kill Mycobacterium tuberculosis, including multidrug-resistant clinical strains. Antimicrob Agents Chemoth, 2013,57(2):1040-1046. | |||
| [11] | Guo H, Ren B, Dai H, Dai S, Zhang Y, Liu Y, Cao B, Zhang L . Reversal of meticillin resistance in Staphylococcus aureus by the anthelmintic avermectin. Int J Antimicrob Agents, 2014,44(3):274-276. | |||
| [12] | Omura S, Crump A . Ivermectin: Panacea for resource-poor communities. Trends Parasitol, 2014,30(9):445-455. | |||
| [13] | Juarez M, Schcolnik-Cabrera A, Due?as-Gonzalez A . The multitargeted drug ivermectin: from an antiparasitic agent to a repositioned cancer drug. Am J Cancer
/
|